Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Kezar Life Sciences receive a clinical hold letter from the FDA by the end of 2024?  | Binary | 3 | 3 months ago | ||
Will Kezar Life Sciences resume enrollment in the Zetomipzomib Lupus Nephritis trial by March 31, 2025? | Binary | 3 | 3 months ago | ||
How will Kezar Life Sciences' stock price change by December 31, 2024? | Categorical | 3 | 3 months ago | ||
Will Kezar Life Sciences announce new safety measures for the Zetomipzomib Lupus Nephritis trial by December 31, 2024? | Binary | 2 | 3 months ago | ||
What will be the outcome of the FDA review of Kezar Life Sciences' Zetomipzomib Lupus Nephritis trial by March 31, 2025? | Categorical | 2 | 3 months ago | ||
What regulatory action will EMA take on Kezar Life Sciences' Zetomipzomib Lupus Nephritis trial by March 31, 2025? | Categorical | 2 | 3 months ago |